rosiglitazone has been researched along with arginine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, R; Kumar, A; Manral, S; Parmar, VS; Prasad, AK; Raj, HG; Rohil, V; Singh, U; Sinha, R; Sushama, A | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abbasi, F; Chu, JW; Cooke, JP; Lamendola, C; McLaughlin, TL; Reaven, GM; Stühlinger, MC; Tsao, PS | 1 |
| Hollingdal, M; Juhl, CB; Lönnqvist, F; Prange, A; Pørksen, N; Schmitz, O | 1 |
| Hu, CP; Jiang, JL; Li, YJ; Wang, S; Yang, DL; Zhang, XJ | 1 |
| Chen, MF; Chen, WJ; Cheng, WC; Lee, YT; Lin, JW; Wang, TD | 1 |
| Kapiotis, S; Krzyzanowska, K; Mittermayer, F; Pleiner, J; Roden, M; Schaller, G; Wolzt, M | 1 |
| Bank, AJ; Gonzalez-Campoy, JM; Kaiser, DR; Kelly, AS; Thelen, AM | 1 |
| Chernichovski, T; Filip, I; Ingbir, M; Levin-Iaina, N; Levo, Y; Reshef, R; Rozovski, U; Schwartz, D; Schwartz, IF; Shtabsky, A | 1 |
| de Vries, TP; Ellger, B; Girbes, AR; Richir, MC; Siroen, MP; Spreeuwenberg, M; Teerlink, T; van den Berghe, G; van der Hoven, B; van Leeuwen, PA; Visser, M; Wilhelm, AJ | 1 |
| Khanduja, KL; Malhotra, S; Pandhi, P; Sidhu, S; Vaiphei, K | 1 |
| John, CC; Kutamba, E; Mugarura, K; Opoka, RO | 1 |
| Higgins, SJ; Kain, KC; Liles, WC | 1 |
3 review(s) available for rosiglitazone and arginine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.
Topics: Antimalarials; Arginine; Erythropoietin; Humans; Levamisole; Malaria, Cerebral; Malaria, Falciparum; Plasmodium falciparum; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2010 |
Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.
Topics: Africa; Antimalarials; Arginine; Clinical Trials as Topic; Dexamethasone; Epidemiologic Studies; Erythropoietin; Humans; Immunomodulation; Inflammation; Levamisole; Malaria, Cerebral; Malaria, Falciparum; Nitric Oxide; Plasmodium falciparum; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2011 |
5 trial(s) available for rosiglitazone and arginine
| Article | Year |
|---|---|
Influence of rosiglitazone treatment on beta-cell function in type 2 diabetes: evidence of an increased ability of glucose to entrain high-frequency insulin pulsatility.
Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Entropy; Female; Glucose; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Middle Aged; Rosiglitazone; Stimulation, Chemical; Thiazoles; Thiazolidinediones | 2003 |
Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome.
Topics: Arginine; Blood Pressure; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Endothelin-1; Endothelium-Dependent Relaxing Factors; Female; Glucose; Humans; Insulin; Male; Metabolic Syndrome; Middle Aged; Regression Analysis; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vasodilator Agents | 2006 |
Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction.
Topics: Acetylcholine; Adult; Anticoagulants; Arginine; C-Reactive Protein; Endothelium, Vascular; Fatty Acids, Nonesterified; Forearm; Heparin; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Methylation; Nitroglycerin; Plethysmography; Regional Blood Flow; Rosiglitazone; Thiazolidinediones; Vasculitis; Vasodilation; Vasodilator Agents | 2007 |
Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Arginine; Biomarkers; Blood Glucose; Blood Pressure; Brachial Artery; C-Reactive Protein; Carotid Arteries; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Elasticity; Endothelium, Vascular; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Male; Metformin; Middle Aged; Oxidative Stress; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vasodilation | 2007 |
The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients.
Topics: Aged; Arginine; Critical Illness; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Rosiglitazone; Thiazolidinediones | 2009 |
8 other study(ies) available for rosiglitazone and arginine
| Article | Year |
|---|---|
Calreticulin Transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds.
Topics: Acetates; Acetylation; Acetyltransferases; Adenosine Diphosphate; Arginine; Blood Platelets; Cells, Cultured; Coumarins; Cyclic GMP; Cytochrome Reductases; Enzyme Inhibitors; Fluoresceins; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; Platelet Aggregation; Polyphenols; Structure-Activity Relationship | 2012 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cross-Sectional Studies; Enzyme Inhibitors; Female; Humans; Hypertension; Hypoglycemic Agents; Lipoproteins; Male; Metabolic Diseases; Metabolic Syndrome; Middle Aged; Nitric Oxide Synthase; Regression Analysis; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; Vasodilator Agents | 2002 |
Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells.
Topics: Acetylcholine; Animals; Aorta; Arginine; Cells, Cultured; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Male; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide Synthase; Nitrites; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Vasodilation | 2007 |
Rosiglitazone improves aortic arginine transport, through inhibition of PKCalpha, in uremic rats.
Topics: Animals; Aorta; Arginine; Biological Transport; Cationic Amino Acid Transporter 1; Disease Models, Animal; Hypoglycemic Agents; Kidney Failure, Chronic; Male; Nitric Oxide; Protein Kinase C-alpha; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Uremia | 2008 |
Rosiglitazone promotes pancreatic regeneration in experimental model of acute pancreatitis.
Topics: Acute Disease; Animals; Arginine; Disease Models, Animal; DNA; Female; Male; Pancreatitis; PPAR gamma; Rats; Rats, Wistar; Regeneration; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Severity of Illness Index; Sincalide; Thiazolidinediones; Time Factors | 2011 |